Last update :
03/05/2024
References   References 3774  
Type : Manufacturer

Research teams :
Authors :
Title : Blinatumomab - (Blincyto®) - Summary of Product Characteristics
Reference : Amgen 2016

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionBlinatumomab Anticancer drug
Stability in solutions Glass Water for Injection 12,5 µg/ml 2-8°C Protect from light
24 Hour
Stability in solutions Glass Water for Injection 12,5 µg/ml 23-27°C Protect from light
4 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,26 µg/ml 2-8°C Not specified
10 Day
Stability in solutions Polyolefine Sodium chloride 0,9% 0,26 µg/ml 23-27°C Not specified
96 Hour
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,9% 0,26 µg/ml 2-8°C Not specified
10 Day
Stability in solutions Ethylene vinyl acetate Sodium chloride 0,9% 0,26 µg/ml 23-27°C Not specified
96 Hour

  Mentions Légales